Clover Health Investments Past Earnings Performance
Past criteria checks 0/6
Clover Health Investments has been growing earnings at an average annual rate of 2.6%, while the Healthcare industry saw earnings growing at 3.6% annually. Revenues have been growing at an average rate of 13.9% per year.
Key information
2.6%
Earnings growth rate
50.1%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 13.9% |
| Return on equity | -37.2% |
| Net Margin | -5.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Clover Health Investments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2,090 | -121 | 418 | 0 |
| 31 Mar 24 | 2,059 | -157 | 422 | 0 |
| 31 Dec 23 | 2,036 | -213 | 445 | 0 |
| 30 Sep 23 | 2,040 | -234 | 457 | 0 |
| 30 Jun 23 | 2,441 | -268 | 473 | 0 |
| 31 Mar 23 | 2,989 | -344 | 486 | 0 |
| 31 Dec 22 | 3,579 | -340 | 487 | 0 |
| 30 Sep 22 | 3,041 | -443 | 476 | 0 |
| 30 Jun 22 | 2,564 | -402 | 478 | 0 |
| 31 Mar 22 | 2,075 | -615 | 468 | 0 |
| 31 Dec 21 | 1,361 | -588 | 446 | 0 |
| 30 Sep 21 | 1,158 | -527 | 387 | 0 |
| 30 Jun 21 | 922 | -487 | 314 | 0 |
| 31 Mar 21 | 721 | -160 | 247 | 0 |
| 31 Dec 20 | 690 | -136 | 192 | 0 |
| 30 Sep 20 | 624 | -89 | 186 | 0 |
| 30 Jun 20 | 572 | -145 | 177 | 0 |
| 31 Mar 20 | 507 | -272 | 185 | 0 |
| 31 Dec 19 | 455 | -364 | 187 | 0 |
| 31 Dec 18 | 281 | -202 | 187 | 0 |
Quality Earnings: 7QD is currently unprofitable.
Growing Profit Margin: 7QD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 7QD is unprofitable, but has reduced losses over the past 5 years at a rate of 2.6% per year.
Accelerating Growth: Unable to compare 7QD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 7QD is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (30.9%).
Return on Equity
High ROE: 7QD has a negative Return on Equity (-37.17%), as it is currently unprofitable.